PolarityTE Stock Forecast, Price & News

-0.07 (-6.86 %)
(As of 04/12/2021 03:54 PM ET)
Today's Range
Now: $0.95
50-Day Range
MA: $1.27
52-Week Range
Now: $0.95
Volume48,298 shs
Average Volume8.50 million shs
Market Capitalization$57.13 million
P/E RatioN/A
Dividend YieldN/A
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
PolarityTE logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:PTE
Year FoundedN/A



Sales & Book Value

Annual Sales$5.65 million
Book Value$1.42 per share


Net Income$-92,490,000.00
Net Margins-674.12%


Market Cap$57.13 million
Next Earnings Date5/10/2021 (Estimated)


PolarityTE: Risk And Reward - Seeking Alpha
April 6, 2021 |
PolarityTE, Inc. to Host Earnings Call - Yahoo Finance
March 30, 2021 |
Recap: PolarityTE Q4 Earnings - Benzinga
March 30, 2021 |
PolarityTE's Earnings Outlook - Yahoo Finance
March 30, 2021 |
PolarityTE, Inc. to Host Earnings Call
March 30, 2021 |
(PTE) - PolarityTE's Earnings Outlook - Benzinga
March 29, 2021 |
PolarityTE's Earnings Outlook
March 29, 2021 |
PolarityTE (PTE) to Release Earnings on Tuesday
March 23, 2021 |
See More Headlines


Overall MarketRank

1.44 out of 5 stars

Medical Sector

596th out of 2,011 stocks

Biological Products, Except Diagnostic Industry

90th out of 176 stocks

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
-0.07 (-6.86 %)
(As of 04/12/2021 03:54 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PTE News and Ratings via Email

Sign-up to receive the latest news and ratings for PTE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

PolarityTE (NASDAQ:PTE) Frequently Asked Questions

Is PolarityTE a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PolarityTE in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PolarityTE stock.
View analyst ratings for PolarityTE
or view top-rated stocks.

What stocks does MarketBeat like better than PolarityTE?

Wall Street analysts have given PolarityTE a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PolarityTE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting PolarityTE?

PolarityTE saw a increase in short interest in March. As of March 15th, there was short interest totaling 3,960,000 shares, an increase of 32.0% from the February 28th total of 3,000,000 shares. Based on an average daily trading volume, of 8,680,000 shares, the days-to-cover ratio is currently 0.5 days.
View PolarityTE's Short Interest

When is PolarityTE's next earnings date?

PolarityTE is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021.
View our earnings forecast for PolarityTE

How were PolarityTE's earnings last quarter?

PolarityTE, Inc. (NASDAQ:PTE) issued its quarterly earnings results on Monday, March, 29th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.23) by $0.03. PolarityTE had a negative net margin of 674.12% and a negative trailing twelve-month return on equity of 169.92%.
View PolarityTE's earnings history

How has PolarityTE's stock price been impacted by Coronavirus?

PolarityTE's stock was trading at $1.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PTE stock has decreased by 11.2% and is now trading at $0.95.
View which stocks have been most impacted by COVID-19

What price target have analysts set for PTE?

4 brokers have issued 12 month target prices for PolarityTE's shares. Their forecasts range from $3.00 to $5.00. On average, they expect PolarityTE's share price to reach $4.00 in the next year. This suggests a possible upside of 321.1% from the stock's current price.
View analysts' price targets for PolarityTE
or view top-rated stocks among Wall Street analysts.

Who are PolarityTE's key executives?

PolarityTE's management team includes the following people:
  • Mr. David B. Seaburg, Chief Exec. Officer (Age 51, Pay $280.16k)
  • Mr. Richard Hague, Pres & COO (Age 61, Pay $377.54k)
  • Mr. Jacob Alexander Patterson, Interim Chief Financial Officer (Age 43)
  • Mr. Nikolai Sopko, Chief Scientific Officer and VP of R&D
  • Mr. Rich Haerle, VP of Investor Relations & Strategy
  • Mr. Cameron J. Hoyler, Gen. Counsel, Sec. and Exec. VP of Corp. Devel. & Strategy (Age 37)
  • Angela Ziegler, VP of Marketing & PR
  • Mr. Alain Adam, VP of Sales
  • Dr. Edward Winslow Swanson, Chief Medical Officer & Co-Founder (Age 36)
  • Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACS, Chief Clinical Officer & Member of Clinical Advisory Board (Age 72)

Who are some of PolarityTE's key competitors?

What other stocks do shareholders of PolarityTE own?

What is PolarityTE's stock symbol?

PolarityTE trades on the NASDAQ under the ticker symbol "PTE."

How do I buy shares of PolarityTE?

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PolarityTE's stock price today?

One share of PTE stock can currently be purchased for approximately $0.95.

How much money does PolarityTE make?

PolarityTE has a market capitalization of $57.13 million and generates $5.65 million in revenue each year. The company earns $-92,490,000.00 in net income (profit) each year or ($3.70) on an earnings per share basis.

How many employees does PolarityTE have?

PolarityTE employs 153 workers across the globe.

What is PolarityTE's official website?

The official website for PolarityTE is

Where are PolarityTE's headquarters?

PolarityTE is headquartered at 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116.

How can I contact PolarityTE?

PolarityTE's mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]

This page was last updated on 4/12/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.